Redcliffe Labs has appointed Kshitiz Singh as Chief Business Officer – Inorganic Growth. In his new role, he has been entrusted with leading the company’s inorganic growth strategy through mergers and acquisitions, strategic partnerships, and post-acquisition integration as it expands its diagnostics network across regional markets in India.
The company has strengthened its leadership team to support the expansion of its integrated diagnostics ecosystem, combining pathology, radiology, technology, and preventive healthcare. Singh has worked closely with the leadership team to identify growth opportunities, integrate regional diagnostic businesses into the company’s operating platform, and strengthen its nationwide diagnostics network.
Singh has brought more than 26 years of leadership experience across diagnostics, healthcare, pharmaceuticals, FMCG, sales leadership, business development, and commercial strategy. Throughout his career, he has led business operations, expanded regional markets, built commercial teams, and driven business growth across multiple organisations.
Prior to joining Redcliffe Labs, Singh has served as General Manager and Business Head at Agilus Diagnostics, where he has led business expansion and market development. Earlier, he has held leadership roles at Piramal Enterprises, Abbott India, Heinz India, Sanofi, AstraZeneca, and GlaxoSmithKline, gaining experience in diagnostics, commercial strategy, business development, channel management, and organisational growth.
Aditya Kandoi, Founder and CEO, Redcliffe Labs, said, “The diagnostics industry is entering a phase where scale, integration, and regional reach will define long-term leadership. Across the country, several strong regional diagnostic businesses have built deep clinical expertise and patient trust. We see a significant opportunity to bring these strengths together through an integrated platform that combines technology, clinical excellence, and preventive healthcare. Kshitiz’s experience across diagnostics and healthcare will help us accelerate this journey while strengthening our presence across regional markets.”
Kshitiz Singh, Chief Business Officer – Inorganic Growth, Redcliffe Labs, said, “India’s diagnostics sector presents a significant opportunity to strengthen healthcare through strategic partnerships and capability building. Redcliffe Labs has built a strong foundation for preventive care driven by its commitment and a clear purpose of adding healthy years to lives. I look forward to working with the leadership to identify the growth opportunities, forge strong partnerships, and strengthen our network to bring trusted, high-quality diagnostics to more people across the country.”
